Falling Earnings Estimates Signal Weakness Ahead for Harte-Hanks (HHS) - Tale of the Tape
Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security before more losses hit your portfolio.
One such stock that you may want to consider dropping is Harte-Hanks Inc. ( HHS ), which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year. A Zacks Rank #4 (Sell) further confirms weakness in HHS.
A key reason for this move has been the negative trend in earnings estimate revisions. For the full year, we have seen 1 estimate moving down in the past 30 days, compared to no upward revision. This trend has caused the consensus estimate to trend lower, going from 29 cents a share a month ago to its current level of 9 cents per share.
Also, for the current quarter, Harte-Hanks has seen 1 downward estimate revision versus no revision in the opposite direction, dragging the consensus estimate down to a loss of 7 cents a share from a loss of 5 cents per share over the past 30 days.
The stock also has seen some pretty dismal trading lately, as the share price has dropped 13.1% in the past month.
So it may not be a good decision to keep this stock in your portfolio anymore, at least if you don't have a long time horizon to wait.
If you are still interested in the Advertising/Marketing Services industry, you may instead consider a better-ranked stock - TubeMogul, Inc. ( TUBE ). The stock currently holds a Zacks Rank #2 (Buy) and may be better selection at this time.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.